Kite, a Gilead Company, today announced the U.S. Food and Drug Administration has granted approval for Tecartus ® for the treatment of adult patients with relapsed or refractory B-cell precursor acute ...
ATLANTA--(BUSINESS WIRE)--Kite, a Gilead Company (Nasdaq: GILD), announced updated results from the ongoing Phase 1/2 ZUMA-3 study of KTE-C19, a CD19 chimeric antigen receptor T (CAR T) cell therapy, ...
Max has set a Thursday, July 18 premiere date for its new adult animated series Kite Man: Hell Yeah!, a spinoff of Harley Quinn. The series debuts with two episodes on July 18, followed by one new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback